Jesus Calahorra
Jaen, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Phenotypic AI-based design of cell-specific small molecule cytotoxics.
Journal: Communications chemistry
Published: November 18, 2025
Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer.
Journal: International journal of biological sciences
Published: February 22, 2025
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy.
Journal: Pharmaceutics
Published: December 19, 2024
Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 30, 2023
The effect of Fe3O4 biosynthesized through the green synthesis of Silybum marianum and HA in the targeted delivery of 5-Fluorouracil to HCT116 cell line.
Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
Published: October 29, 2023
Tyrosol: Repercussion of the Lack of a Hydroxyl-Group in the Response of MCF-7 Cells to Hypoxia.
Journal: Journal of medicinal food
Published: June 28, 2023
TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression.
Journal: International journal of biological sciences
Published: September 09, 2022
Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer.
Journal: Pharmaceutics
Published: January 12, 2022
Impact of hydroxytyrosol on stroke: tracking therapy response on neuroinflammation and cerebrovascular parameters using PET-MR imaging and on functional outcomes.
Journal: Theranostics
Published: May 12, 2020
Crosstalk between hydroxytyrosol, a major olive oil phenol, and HIF-1 in MCF-7 breast cancer cells.
Journal: Scientific reports
Published: June 28, 2019
Last Updated: 09/26/2026